Core Viewpoint - The author emphasizes a preference for the terms "contributor" or "author" over "analyst," indicating a shift from professional analysis to sharing personal views on investment opportunities and discussions [1][3]. Group 1: Background and Experience - The author has over 30 years of personal investment experience in the stock market and has worked in various roles within the financial industry, including as a buy-side analyst and fund co-manager [1]. - Experience includes working at a leading mutual fund company focusing on long-only stock market investments, particularly in financial companies, with a strong emphasis on fundamental analysis and market news [1]. - The author has also worked at a multi-billion dollar hedge fund, gaining insights into capital structures, arbitrage, and M&A situations [1]. - A transition to a financial regulatory authority provided the author with insights into international regulation and corporate governance, enhancing the ability to analyze companies [1]. Group 2: Insights and Analysis - Extensive interactions with corporate executives through various events have provided the author with unique insights into company operations and strategies [1]. - The author highlights the importance of understanding the context behind corporate communications, suggesting that messages are tailored for specific audiences and should be interpreted cautiously [1]. Group 3: Current Position and Intent - The author aims to share independent views and engage in discussions with the public, leveraging past experiences while adhering to compliance regulations by focusing on publicly available information [1]. - The author clarifies that the content shared is not intended as investment advice and encourages readers to conduct their own research [3][4].

As filed with the Securities and Exchange Commission on September 6, 2024 Registration No. 333-281831 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 GREENLANE HOLDINGS, INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organization) Delaware 5099 83-0806637 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identificati ...

As filed with the Securities and Exchange Commission on January 31, 2024 Registration Statement No. 333-276505 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to Dr. Neergaards Vej 5F 2970 Hørsholm Denmark Telephone: +45 31 31 97 53 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Christian Kanstrup Chief Executive Officer Evaxion Biotech A/S Dr. Neergaards Vej 5F 2970 Hørsholm Denmark Telephone: +45 ...